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Endogenous retroviruses (ERVs) are typically defined as
retroviruses that have integrated into the germline of their
vertebrate hosts and are then passed vertically from parent
to offspring. The human genome sequence contains
approximately 100,000 ERV loci, but none are active (rep-
lication-competent), typically as the result of mutations
introduced during replication of the host genome.
The only ERV lineage that has been replicating in humans
since the human-chimp divergence is the HERV-K(HML2)
family. Some of its loci are unfixed in the human popula-
tion, have intact ORFs, and little or no sequence diver-
gence between their flanking LTRs (which are identical at
integration) [1]. This family also has the strongest link to
disease, including having an accessory gene which causes
cancers when injected into immunocompromised mice
[2]. Two groups have used 'fossil' HERV-K(HML2)
sequences to reconstruct active viruses [3,4], and we
believe that the likelihood that the family causes disease
depends on whether or not it is still active today.
No active HERV-K(HML2) loci have been found, but this
does not mean that the family has itself ceased replicating.
The human genome sequence contains only ERV loci
which have drifted to, or near, fixation, and such loci will
by definition be old and thus likely to have accrued inac-
tivating mutations. By contrast, active ERVs, if they exist,
will be at low allele frequencies (Figure 1).
We have already shown that the proportion of unfixed
loci in a small sample of human individuals is consistent
with the family being active today [5], and - thanks to a
recent Wellcome Trust grant - are currently investigating a
much larger sample size, which should give us the statisti-
cal power to determine whether or not this family is still
replicationally active today. We also hope to find intact
loci, which we will investigate experimentally for infectiv-
ity.
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Conceptual model of ERV evolutionFigure 1
Conceptual model of ERV evolution. Circles represent individual ERV loci and the tree their genealogical relationships. 
Newly integrated, active loci will be present initially only in single host individuals and must eventually be inactivated (and ren-
dered neutral if originally harmful) by mutations acquired during host replication. A small proportion of these loci (= 1/2Ne 
where Ne is the long-term effective population size) will eventually drift to fixation in the host population and thus appear in 
any published genome sequence. If active ERV loci are harmful, they will be found at even lower frequencies (until inactivated 
or lost due to negative selection).Page 2 of 2
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